18 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.
AL-LAD at D2: Kᵢ 270 nM, Jain et al. 2025 AL-LAD at D3: Kᵢ 27 nM, Jain et al. 2025 AL-LAD at D4: Kᵢ 150 nM, Jain et al. 2025 LSD at D2: Kᵢ 39 nM, other reports differ, Janowsky et al. 2014 LSD at D3: Kᵢ 27 nM, other reports differ, Janowsky et al. 2014 LSD at D4: Kᵢ 330 nM, Janowsky et al. 2014 ETH-LAD at D2: Kᵢ 160 nM, Jain et al. 2025 ETH-LAD at D3: Kᵢ 81 nM, Jain et al. 2025 ETH-LAD at D4: Kᵢ 240 nM, Jain et al. 2025 5-MeO-DMT at D2: Kᵢ 3562 nM, Ray 2010 5-MeO-DMT at D3: Kᵢ 498 nM, Ray 2010 5-MeO-DMT at D4: Kᵢ 3120 nM, Ray 2010 Psilocin at D2: Kᵢ 3700 nM, Rickli et al. 2016 Psilocin at D3: Kᵢ 910 nM, other reports differ, Jain et al. 2025 Psilocin at D4: Kᵢ 1700 nM, Jain et al. 2025 Mescaline at D2: Kᵢ 300 nM, Jain et al. 2025 Mescaline at D4: Kᵢ 460 nM, Jain et al. 2025 Mescaline at D3: Kᵢ of 10 µM or weaker Methylone at D3: Kᵢ 460 nM, Jain et al. 2025 Methylone at D4: Kᵢ 1100 nM, Jain et al. 2025 Methylone at D2: Kᵢ of 10 µM or weaker 2C-E at D2: Kᵢ 3200 nM, Rickli et al. 2015 2C-E at D3: Kᵢ 1345 nM, Ray 2010 2C-E at D4: Kᵢ of 10 µM or weaker 2C-B at D2: Kᵢ 2200 nM, Rickli et al. 2015 2C-B at D3: Kᵢ 7116 nM, Ray 2010 2C-B at D4: Kᵢ of 10 µM or weaker 2C-P at D2: Kᵢ 2300 nM, Rickli et al. 2015 2C-P at D3: Kᵢ 5200 nM, Rickli et al. 2015 5-MeO-MiPT at D3: Kᵢ 2470 nM, Ray 2010 5-MeO-MiPT at D4: Kᵢ 6331 nM, Ray 2010 5-MeO-MiPT at D2: Kᵢ of 10 µM or weaker 2C-I at D2: Kᵢ 2700 nM, Rickli et al. 2015 2C-I at D3: Kᵢ 5000 nM, Rickli et al. 2015 DMT at D2: Kᵢ 3000 nM, Rickli et al. 2016 DMT at D3: Kᵢ 6300 nM, Rickli et al. 2016 DMT at D4: Kᵢ of 10 µM or weaker 4-HO-MET at D2: Kᵢ 4000 nM, Rickli et al. 2016 4-HO-MET at D3: Kᵢ 6700 nM, Rickli et al. 2016 DOI at D3: Kᵢ 690 nM, Jain et al. 2025 DOI at D2: Kᵢ of 10 µM or weaker DOI at D4: Kᵢ of 10 µM or weaker DOB at D3: Kᵢ 808 nM, Ray 2010 DOB at D2: Kᵢ of 10 µM or weaker DOB at D4: Kᵢ of 10 µM or weaker 2C-C at D2: Kᵢ 2100 nM, Rickli et al. 2015 2C-C at D3: Kᵢ of 10 µM or weaker 2C-D at D2: Kᵢ 7100 nM, Rickli et al. 2015 2C-D at D3: Kᵢ of 10 µM or weaker D2 receptor D2 D3 receptor D3 D4 receptor D4 AL-LAD, Kᵢ: D2 270 nM, D3 27 nM, D4 150 nM AL-LAD LSD, Kᵢ: D2 39 nM, D3 27 nM, D4 330 nM LSD ETH-LAD, Kᵢ: D2 160 nM, D3 81 nM, D4 240 nM ETH-LAD 5-MeO-DMT, Kᵢ: D2 3562 nM, D3 498 nM, D4 3120 nM 5-MeO-DMT Psilocin, Kᵢ: D2 3700 nM, D3 910 nM, D4 1700 nM Psilocin Mescaline, Kᵢ: D2 300 nM, D3 10 µM or weaker, D4 460 nM Mescaline Methylone, Kᵢ: D2 10 µM or weaker, D3 460 nM, D4 1100 nM Methylone 2C-E, Kᵢ: D2 3200 nM, D3 1345 nM, D4 10 µM or weaker 2C-E 2C-B, Kᵢ: D2 2200 nM, D3 7116 nM, D4 10 µM or weaker 2C-B 2C-P, Kᵢ: D2 2300 nM, D3 5200 nM 2C-P 5-MeO-MiPT, Kᵢ: D2 10 µM or weaker, D3 2470 nM, D4 6331 nM 5-MeO-MiPT 2C-I, Kᵢ: D2 2700 nM, D3 5000 nM 2C-I DMT, Kᵢ: D2 3000 nM, D3 6300 nM, D4 10 µM or weaker DMT 4-HO-MET, Kᵢ: D2 4000 nM, D3 6700 nM 4-HO-MET DOI, Kᵢ: D2 10 µM or weaker, D3 690 nM, D4 10 µM or weaker DOI DOB, Kᵢ: D2 10 µM or weaker, D3 808 nM, D4 10 µM or weaker DOB 2C-C, Kᵢ: D2 2100 nM, D3 10 µM or weaker 2C-C 2C-D, Kᵢ: D2 7100 nM, D3 10 µM or weaker 2C-D 270 nM 27 nM 150 nM 39 nM 27 nM 330 nM 160 nM 81 nM 240 nM 3562 nM 498 nM 3120 nM 3700 nM 910 nM 1700 nM 300 nM 460 nM 460 nM 1100 nM 3200 nM 1345 nM 2200 nM 7116 nM 2300 nM 5200 nM 2470 nM 6331 nM 2700 nM 5000 nM 3000 nM 6300 nM 4000 nM 6700 nM 690 nM 808 nM 2100 nM 7100 nM
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”
Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.